• OCT2 and MATE1 Inhibition by Antiemetic Drugs

  2026-09-22

  George et al. systematically compared five 5-HT3 antagonists for inhibition of the renal organic cation transporters OCT2 and MATE1, combining transporter-overexpressing cells with a polarized transcellular model. The study identifies strong, transporter-selective differences in potency and shows that ondansetron can increase intracellular cation accumulation, supporting a mechanistic basis for drug–drug interactions involving renal secretion.

• CAY10499 for Lipid-Linked Cell Assay Design

  2026-09-21

  A scenario-based guide to using CAY10499, a potent inhibitor of human hormone sensitive lipase and monoglyceride lipase, as a mechanistic control in lipid-metabolism and cell-assay workflows. It explains assay compatibility, solvent handling, interpretation limits, and selection considerations for SKU B7841.

• AMG 487: A Context-Aware CXCR3 Tool

  2026-09-21

  AMG 487 is a selective CXCR3 antagonist for dissecting chemokine signaling, migration, calcium flux, and macrophage-state transitions. This article explains how inflammatory context and LAMP1-linked autophagy determine the meaning of CXCR3 inhibition in advanced assays.

• WRN–MMR Synthetic Lethality in MSI Colorectal Cancer

  2026-09-20

  This PNAS study defines a p53/PUMA-dependent apoptotic mechanism that explains why mismatch repair-deficient, microsatellite-instable colorectal cancer cells are selectively vulnerable to Werner helicase loss. Genetic depletion, rescue experiments, and xenograft models support WRN as a context-dependent therapeutic target, while the pharmacological data illustrate how RecQ helicase probes can be evaluated in genotype-matched cancer models.

• Targeted Non-Viral Gene Delivery to Adipocytes

  2026-09-19

  The reference study introduced ATS-9R as a fusion oligopeptide that combines adipocyte recognition through Prohibitin with a nona-arginine nucleic-acid delivery domain. In obese mice, an ATS-9R/shFABP4 complex enabled adipocyte-directed gene silencing, metabolic recovery, and more than 20% body-weight reduction, establishing a foundation for targeted non-viral delivery in obesity research.

• TRPV4-to-Assay Translation with Rabbit IgG Detection

  2026-09-18

  A translational framework linking TRPV4–P2X purinergic signaling in cough hypersensitivity with rigorous, reproducible rabbit IgG immunodetection across Western blotting, ELISA, IHC, and immunocytochemistry.

• Gemcitabine HCl in MRI-Guided Tumor Studies

  2026-09-18

  Connect nanomolar cell-killing data with longitudinal, anatomy-resolved tumor measurements in pancreatic cancer models. This workflow uses Gemcitabine HCl to align cytotoxicity testing, treatment scheduling, and multianimal MRI while separating biological response from measurement variability.

• AMG 487: A Practical CXCR3 Antagonist Workflow

  2026-09-17

  AMG 487 enables receptor-focused analysis of CXCR3 signaling across chemotaxis, calcium flux, and macrophage polarization. This guide translates the CXCL10–CXCR3–LAMP1 findings into state-aware assay workflows, controls, and troubleshooting decisions.

• Nutlin-3a: Reframing MDM2–p53 Translation

  2026-09-17

  Nutlin-3a is more than a conventional MDM2 inhibitor: it is a pharmacological probe for testing how p53 state, ferroptotic vulnerability, migration, and tumor-cell survival intersect. This article translates evidence from glioblastoma biology into a disciplined experimental strategy while clarifying where the data support a hypothesis—and where they do not yet justify a therapeutic conclusion.

• Dabigatran Etexilate: Assay-Ready Thrombin Biology

  2026-09-16

  Dabigatran etexilate is an oral prodrug and direct thrombin inhibitor with important implications for translational coagulation assays. This guide connects its activation chemistry, thrombin inhibition mechanism, clotting endpoints, and practical handling decisions for research workflows.

• One-step TUNEL Cy3 Apoptosis Detection Kit

  2026-09-16

  Map apoptotic DNA fragmentation in tissue sections or cultured cells with a Cy3-based workflow designed for microscopy and flow cytometry. Practical controls, assay parameters, and troubleshooting guidance help distinguish genuine treatment-associated apoptosis from preparation artifacts.

• Itraconazole Workflows for Candida Biofilm Research

  2026-09-15

  Build more informative Candida assays by pairing Itraconazole exposure with biofilm maturity, PP2A-autophagy status, and orthogonal viability readouts. The workflow also separates antifungal screening from CYP3A4, hedgehog, and angiogenesis applications so results remain mechanistically interpretable.

• JAK Inhibitors and Endothelial Cardiovascular Effects

  2026-09-15

  A 2025 ACR Open Rheumatology study compared several JAK inhibitors in human endothelial cells exposed to combined TNF and IL-17A. Although all agents reduced IL-6 release, their effects on IL-8, adhesion molecules, tissue factor, thrombomodulin, and endothelial survival differed substantially, showing that anti-inflammatory activity does not necessarily indicate vascular protection.

• 3D Au Nanocluster Arrays by Polymer Pen Lithography

  2026-09-14

  The reference study presents polymer pen lithography as a controllable route to three-dimensional gold nanoparticle cluster arrays for surface-enhanced Raman scattering. By combining patterned polyethylenimine structures with electrostatic nanoparticle assembly, the authors obtain strong enhancement, low signal variation, and tunable array architectures without relying on more costly conventional nanolithography.

• SM-164 and the New Logic of Apoptotic Signaling

  2026-09-14

  RNA Pol II degradation and IAP antagonism offer distinct examples of actively signaled cell death. This thought-leadership analysis positions SM-164 as a practical bivalent Smac mimetic for testing TNFα-dependent apoptosis, while outlining how translational researchers can separate mechanism, biomarker response, and therapeutic hypothesis.

8018 records 1/535 page Next 12345 下5页 Last page